GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Woojung Bio Inc (XKRX:215380) » Definitions » Scaled Net Operating Assets

Woojung Bio (XKRX:215380) Scaled Net Operating Assets : 0.86 (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Woojung Bio Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Woojung Bio's operating assets for the quarter that ended in Dec. 2024 was ₩90,251 Mil. Woojung Bio's operating liabilities for the quarter that ended in Dec. 2024 was ₩14,341 Mil. Woojung Bio's Total Assets for the quarter that ended in Sep. 2024 was ₩88,135 Mil. Therefore, Woojung Bio's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was 0.86.


Woojung Bio Scaled Net Operating Assets Historical Data

The historical data trend for Woojung Bio's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Woojung Bio Scaled Net Operating Assets Chart

Woojung Bio Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.65 0.91 0.65 0.72 0.77

Woojung Bio Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.71 0.69 0.76 0.81 0.86

Competitive Comparison of Woojung Bio's Scaled Net Operating Assets

For the Biotechnology subindustry, Woojung Bio's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Woojung Bio's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Woojung Bio's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Woojung Bio's Scaled Net Operating Assets falls into.


;
;

Woojung Bio Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Woojung Bio's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2024 )
=(Operating Assets (A: Dec. 2024 )-Operating Liabilities (A: Dec. 2024 ))/Total Assets (A: Dec. 2023 )
=(90251.368-14341.396)/98332.604
=0.77

where

Operating Assets(A: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=94699.062 - 4447.694
=90251.368

Operating Liabilities(A: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=65326.105 - 30547.329 - 20437.38
=14341.396

Woojung Bio's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2024 )
=(Operating Assets (Q: Dec. 2024 )-Operating Liabilities (Q: Dec. 2024 ))/Total Assets (Q: Sep. 2024 )
=(90251.368-14341.396)/88134.685
=0.86

where

Operating Assets(Q: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=94699.062 - 4447.694
=90251.368

Operating Liabilities(Q: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=65326.105 - 30547.329 - 20437.38
=14341.396

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Woojung Bio Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Woojung Bio's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Woojung Bio Business Description

Traded in Other Exchanges
N/A
Address
Gwanggyo-ro 145, B-dong 3rd Floor, Next Generation Convergence Technology Research Center, Gyeonggi-do, Yeongtong-gu, Suwon-si, KOR
Woojung Bio Inc is engaged in the research and development of natural science and engineering. Its products include Gene Delivery, Antibody Production, Immunodeficiency model, Human-to-human model, Zika, Mers, Dengue, Influenza Virus Research, Influenza virus, vaccine studies, and Elegant Goettingen Mini Pig.

Woojung Bio Headlines

No Headlines